TRANSLUCENT BROAD SPECTRUM FOUNDATION SPF 50 VERTRA- padimate o, titanium dioxide stick United States - English - NLM (National Library of Medicine)

translucent broad spectrum foundation spf 50 vertra- padimate o, titanium dioxide stick

eai-jr286, inc. - padimate o (unii: z11006cmuz) (padimate o - unii:z11006cmuz), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - padimate o 7 g in 100 g - uses - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun - higher spf gives more sunburn protection - retains spf after 80 minutes activity in the water, sweating, or perspiring - provides high protection against sunburn stop use and ask a doctor if rash or irritation develops and lasts

TRANSLUCENT BROAD SPECTRUM FOUNDATION SPF 50 VERTRA- padimate o, titanium dioxide stick United States - English - NLM (National Library of Medicine)

translucent broad spectrum foundation spf 50 vertra- padimate o, titanium dioxide stick

toshiki pigment co., ltd. - padimate o (unii: z11006cmuz) (padimate o - unii:z11006cmuz), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp) - uses - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun - higher spf gives more sunburn protection - retains spf after 80 minutes activity in the water, sweating, or perspiring - provides high protection against sunburn stop use and ask a doctor if rash or irritation develops and lasts

PROSTIN E2 VAGINAL GEL 2mg Australia - English - Department of Health (Therapeutic Goods Administration)

prostin e2 vaginal gel 2mg

pfizer australia pty ltd - dinoprostone, quantity: 0.6667 mg/g - gel - excipient ingredients: colloidal anhydrous silica; triacetin - for induction of labour in term or near-term pregnant women who have favourable induction features. indications as at 27 august 2003: induction of labour in term or near-term pregnant women who have favourable induction features; and who have singleton pregnancy with a vertex presentation.

PROSTIN E2 VAGINAL GEL 1mg Australia - English - Department of Health (Therapeutic Goods Administration)

prostin e2 vaginal gel 1mg

pfizer australia pty ltd - dinoprostone, quantity: 0.3333 mg/g - gel - excipient ingredients: colloidal anhydrous silica; triacetin - for induction of labour in term or near-term pregnant women who have favourable induction features. indications as at 27 august 2003: induction of labour in term or near-term pregnant women who have favourable induction features; and who have singleton pregnancy with a vertex presentation.

Cable/lead, electrocardiograph, radiolucent Australia - English - Department of Health (Therapeutic Goods Administration)

cable/lead, electrocardiograph, radiolucent

ge healthcare australia pty ltd - 36038 - cable/lead, electrocardiograph, radiolucent - these cables are intended for the transmission of electrical signals from the patient's heart to the ecg machine. these cable leads are intended to be attached to the chest in a given pattern by using electrodes. these cables are specially designed for use during eg cardiac catheterization procedures, because they are intended to cast slight or negligible radiographic images.

Cable/lead, electrocardiograph, radiolucent Australia - English - Department of Health (Therapeutic Goods Administration)

cable/lead, electrocardiograph, radiolucent

ge healthcare australia pty ltd - 36038 - cable/lead, electrocardiograph, radiolucent - the multi-link ecg leadwire sets enable ecg monitoring with ge healthcare equipment requiring rectangular 11-pin ecg trunk cable or with ecg compatibility cables with multi-link leadwire set connection. use leadwire sets with ecg trunk cable or telemetry transmitter. these accessories are indicated for use by qualified medical personnel only. the multi-link din converter products are intended for use with multi-link care ecg trunk cables for adult and pediatric patients in multiple care areas within a professional healthcare facility. this product is indicated for use by qualified medical personnel only.

Cable/lead, electrocardiograph, radiolucent Australia - English - Department of Health (Therapeutic Goods Administration)

cable/lead, electrocardiograph, radiolucent

airlife australia holdings pty ltd - 36038 - cable/lead, electrocardiograph, radiolucent - a device for the transmission of electrical signals from the patient's heart to the electrocardiograph (ecg) machine. the cable leads are attached to the chest in a given pattern by using electrodes. this cable is specially designed for use during, e.g. cardiac catheterization procedures, because it will cast slight or negligible radiographic images.